Ginsenoside compound K alleviates d-galactose-induced mild cognitive impairment by modulating gut microbiota-mediated short-chain fatty acid metabolism

Ginsenoside compound K ameliorates d -galactose-induced mild cognitive impairment by modulating the gut microbiota, increasing the abundance of beneficial Akkermansia , regulating propionate metabolism, and inhibiting the TLR4/NF-κB signaling pathway.